Beals–Hecht syndrome and choroidal neovascularization

Beals–Hecht syndrome and choroidal neovascularization

Roberto Gallego-Pinazo1, Ruth López-Lizcano1, José María Millán2,3, J Fernando Arevalo5, J Luis Mullor6, Manuel Díaz-Llopis1,3,41Department of Ophthalmology, 2Department of Genetics, Unit of Experimental Opthalmology, Hospita...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roberto Gallego-Pinazo, Ruth López-Lizcano, José María Millán, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/699b8581a05a4d5d8436a03a7c6db40e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:699b8581a05a4d5d8436a03a7c6db40e
record_format dspace
spelling oai:doaj.org-article:699b8581a05a4d5d8436a03a7c6db40e2021-12-02T01:21:10ZBeals–Hecht syndrome and choroidal neovascularization1177-54671177-5483https://doaj.org/article/699b8581a05a4d5d8436a03a7c6db40e2010-07-01T00:00:00Zhttp://www.dovepress.com/bealsndashhecht-syndrome-and-choroidal-neovascularization-a4919https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Roberto Gallego-Pinazo1, Ruth López-Lizcano1, José María Millán2,3, J Fernando Arevalo5, J Luis Mullor6, Manuel Díaz-Llopis1,3,41Department of Ophthalmology, 2Department of Genetics, Unit of Experimental Opthalmology, Hospital Universitario La Fe, Valencia, Spain; 3Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain; 4Faculty of Medicine, University of Valencia, Valencia, Spain; 5Retina and Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela; 6Unit of Experimental Opthalmology, Fundación Parala Investigación del Hospital La Fe, Valencia, SpainPurpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals–Hecht syndrome.Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered.Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored.Conclusions: To our knowledge this is the first report of CNV in Beals–Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.Keywords: Beals–Hecht syndrome, connective tissue disease, choroidal neovascularization, ranibizumab Roberto Gallego-PinazoRuth López-LizcanoJosé María Millánet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2010, Iss default, Pp 845-847 (2010)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Roberto Gallego-Pinazo
Ruth López-Lizcano
José María Millán
et al
Beals–Hecht syndrome and choroidal neovascularization
description Roberto Gallego-Pinazo1, Ruth López-Lizcano1, José María Millán2,3, J Fernando Arevalo5, J Luis Mullor6, Manuel Díaz-Llopis1,3,41Department of Ophthalmology, 2Department of Genetics, Unit of Experimental Opthalmology, Hospital Universitario La Fe, Valencia, Spain; 3Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain; 4Faculty of Medicine, University of Valencia, Valencia, Spain; 5Retina and Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela; 6Unit of Experimental Opthalmology, Fundación Parala Investigación del Hospital La Fe, Valencia, SpainPurpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals–Hecht syndrome.Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered.Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored.Conclusions: To our knowledge this is the first report of CNV in Beals–Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.Keywords: Beals–Hecht syndrome, connective tissue disease, choroidal neovascularization, ranibizumab
format article
author Roberto Gallego-Pinazo
Ruth López-Lizcano
José María Millán
et al
author_facet Roberto Gallego-Pinazo
Ruth López-Lizcano
José María Millán
et al
author_sort Roberto Gallego-Pinazo
title Beals–Hecht syndrome and choroidal neovascularization
title_short Beals–Hecht syndrome and choroidal neovascularization
title_full Beals–Hecht syndrome and choroidal neovascularization
title_fullStr Beals–Hecht syndrome and choroidal neovascularization
title_full_unstemmed Beals–Hecht syndrome and choroidal neovascularization
title_sort beals–hecht syndrome and choroidal neovascularization
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/699b8581a05a4d5d8436a03a7c6db40e
work_keys_str_mv AT robertogallegopinazo bealsampndashhechtsyndromeandchoroidalneovascularization
AT ruthlampoacutepezlizcano bealsampndashhechtsyndromeandchoroidalneovascularization
AT josampeacutemarampiacuteamillampaacuten bealsampndashhechtsyndromeandchoroidalneovascularization
AT etal bealsampndashhechtsyndromeandchoroidalneovascularization
_version_ 1718403142089965568

Ejemplares similares